Digoxin Inj.Sol. 0.25mg/ml (2ml Amp) (EU CTD Available)

Product description

Digoxin 0.25mg/ml Solution for Injection (2ml Amp)
Reference Product: Lanoxin® / GSK
Description: Digoxin is indicated in the management of chronic cardiac failure especially where cardiac failure is accompanied by atrial fibrillation, Supraventricular arrhythmias particularly chronic atrial fibrillation and flutter, where its major beneficial effect is to reduce the ventricular rate and when emergency parenteral digitilisation is required in patients who have not been given cardiac glycosides within the preceding two weeks. 
Dossier Status: EU CTD Available
Stability Studies: Zone II / Zone IVb
Shelf life: Three (3) years
Batch Sizes: 40,000 Ampoules
Pack Sizes: BT x 6 Ampoules
Read more

Specifications

Categories Pharmaceutical Products / ATC coding | Cardiovascular SystemCardiac Therapy; Finished Dosage FormsInjectables; Finished Dosage FormsOut-licensing
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Greece

More products from ANFARM HELLAS S.A.

View all our products (37)
Digoxin Inj.Sol. 0.25mg/ml (2ml Amp) (EU CTD Available)

Contact information

Address

Telephone

Website

View all contact information
CAPSULE CORE COMPETENCY

CAPSULE CORE COMPETENCY

Lonza

Lonza

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO ANALYTICAL DEVELOPMENT

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO A...

Elevate your expectations. Demand more from your CDMO.

Elevate your expectations. Demand more from your CDMO.

CONTENT GROUP

CONTENT GROUP